Cheng-Fei Du

Zhejiang Provincial People's Hospital

Papers

1

Total Citations

9

H-Index

1

About

Cheng-Fei Du is a leading hepatobiliary surgeon and researcher whose work focuses on advancing minimally invasive surgical techniques for liver cancer, particularly hepatocellular carcinoma. His major contributions center on comparing the safety and efficacy of laparoscopic versus robotic complex hepatectomy, using rigorous propensity score-matched analyses to guide clinical decision-making. His most-cited study, a multicenter analysis published in 2024, demonstrated that robotic surgery offers comparable perioperative morbidity to laparoscopic approaches for solitary hepatocellular carcinoma, providing critical evidence for surgical innovation. With over 9 citations on this key paper alone, Du’s work has quickly gained traction among peers seeking to optimize patient outcomes through technology. His research is notable for its emphasis on large-scale, real-world data and collaborative multicenter designs, which enhance the generalizability of findings. By systematically evaluating surgical risks and benefits, Du helps shape best practices in complex liver resections, making him a valuable voice in the ongoing evolution of oncologic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Multicenter propensity score-matched analysis to compare perioperative morbidity after laparoscopic or robotic complex hepatectomy for solitary hepatocellular carcinoma
9 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Zhejiang Provincial People's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago